Verburg FA - Search Results

1

Endogenous TSH levels at the time of ¹³¹I ablation do not influence ablation success, recurrence-free survival or differentiated thyroid cancer-related mortality.

Vrachimis A, Riemann B, Mäder U, Reiners C, Verburg FA. Vrachimis A, et al. Among authors: verburg fa. Eur J Nucl Med Mol Imaging. 2016 Feb;43(2):224-231. doi: 10.1007/s00259-015-3223-2. Epub 2015 Oct 23. Eur J Nucl Med Mol Imaging. 2016. PMID: 26493309

2

Why radioiodine remnant ablation is right for most patients with differentiated thyroid carcinoma.

Verburg FA, Dietlein M, Lassmann M, Luster M, Reiners C. Verburg FA, et al. Eur J Nucl Med Mol Imaging. 2009 Mar;36(3):343-6. doi: 10.1007/s00259-008-0997-5. Eur J Nucl Med Mol Imaging. 2009. PMID: 19050874 Review. No abstract available.

3

Primary tumour diameter as a risk factor for advanced disease features of differentiated thyroid carcinoma.

Verburg FA, Mäder U, Luster M, Reiners C. Verburg FA, et al. Clin Endocrinol (Oxf). 2009 Aug;71(2):291-7. doi: 10.1111/j.1365-2265.2008.03482.x. Epub 2008 Dec 3. Clin Endocrinol (Oxf). 2009. PMID: 19067727

4

Histology does not influence prognosis in differentiated thyroid carcinoma when accounting for age, tumour diameter, invasive growth and metastases.

Verburg FA, Mäder U, Luster M, Reiners C. Verburg FA, et al. Eur J Endocrinol. 2009 Apr;160(4):619-24. doi: 10.1530/EJE-08-0805. Epub 2009 Jan 21. Eur J Endocrinol. 2009. PMID: 19158232

5

Potency and tolerance of calcitonin stimulation with high-dose calcium versus pentagastrin in normal adults.

Doyle P, Düren C, Nerlich K, Verburg FA, Grelle I, Jahn H, Fassnacht M, Mäder U, Reiners C, Luster M. Doyle P, et al. Among authors: verburg fa. J Clin Endocrinol Metab. 2009 Aug;94(8):2970-4. doi: 10.1210/jc.2008-2403. Epub 2009 Jun 2. J Clin Endocrinol Metab. 2009. PMID: 19491231

6

Intratracheal growth of recurrent benign goiter.

Verburg FA, Gasser M, Beissert M, Geissinger E, Luster M, Reiners C. Verburg FA, et al. Thyroid. 2009 Sep;19(9):1009-11. doi: 10.1089/thy.2009.0067. Thyroid. 2009. PMID: 19731981

7

Recombinant thyrotropin use in children and adolescents with differentiated thyroid cancer: a multicenter retrospective study.

Luster M, Handkiewicz-Junak D, Grossi A, Zacharin M, Taïeb D, Cruz O, Hitzel A, Casas JA, Mäder U, Dottorini ME; Pediatric rhTSH Investigators Group. Luster M, et al. J Clin Endocrinol Metab. 2009 Oct;94(10):3948-53. doi: 10.1210/jc.2009-0593. Epub 2009 Sep 22. J Clin Endocrinol Metab. 2009. PMID: 19773393

8

A comparison of prognostic classification systems for differentiated thyroid carcinoma.

Verburg FA, Mäder U, Kruitwagen CL, Luster M, Reiners C. Verburg FA, et al. Clin Endocrinol (Oxf). 2010 Jun;72(6):830-8. doi: 10.1111/j.1365-2265.2009.03734.x. Epub 2009 Oct 31. Clin Endocrinol (Oxf). 2010. PMID: 19863574

9

Dosimetry-guided high-activity (131)I therapy in patients with advanced differentiated thyroid carcinoma: initial experience.

Verburg FA, Hänscheid H, Biko J, Hategan MC, Lassmann M, Kreissl MC, Reiners C, Luster M. Verburg FA, et al. Eur J Nucl Med Mol Imaging. 2010 May;37(5):896-903. doi: 10.1007/s00259-009-1303-x. Epub 2009 Dec 24. Eur J Nucl Med Mol Imaging. 2010. PMID: 20033685

10

No survival difference after successful (131)I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer.

Verburg FA, Stokkel MP, Düren C, Verkooijen RB, Mäder U, van Isselt JW, Marlowe RJ, Smit JW, Reiners C, Luster M. Verburg FA, et al. Eur J Nucl Med Mol Imaging. 2010 Feb;37(2):276-83. doi: 10.1007/s00259-009-1315-6. Epub 2009 Nov 29. Eur J Nucl Med Mol Imaging. 2010. PMID: 20091165

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

261 results

Search Page

Filters